Lee MS - Search Results

1

Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy.

Lee MS, Kantarjian H, Talpaz M, Freireich EJ, Deisseroth A, Trujillo JM, Stass SA. Lee MS, et al. Blood. 1992 Apr 15;79(8):1920-3. Blood. 1992. PMID: 1562719 Free article.

2

RAS mutations are rare events in Philadelphia chromosome-negative/bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia.

Hirsch-Ginsberg C, LeMaistre AC, Kantarjian H, Talpaz M, Cork A, Freireich EJ, Trujillo JM, Lee MS, Stass SA. Hirsch-Ginsberg C, et al. Among authors: lee ms. Blood. 1990 Sep 15;76(6):1214-9. Blood. 1990. PMID: 2205309 Free article.

3

Detection of minimal residual bcr/abl transcripts by a modified polymerase chain reaction.

Lee MS, Chang KS, Freireich EJ, Kantarjian HM, Talpaz M, Trujillo JM, Stass SA. Lee MS, et al. Blood. 1988 Sep;72(3):893-7. Blood. 1988. PMID: 2458151 Free article.

4

Ras oncogene mutations are rare late stage events in chronic myelogenous leukemia.

LeMaistre A, Lee MS, Talpaz M, Kantarjian HM, Freireich EJ, Deisseroth AB, Trujillo JM, Stass SA. LeMaistre A, et al. Among authors: lee ms. Blood. 1989 Mar;73(4):889-91. Blood. 1989. PMID: 2645949 Free article.

5

Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction.

Lee MS, LeMaistre A, Kantarjian HM, Talpaz M, Freireich EJ, Trujillo JM, Stass SA. Lee MS, et al. Blood. 1989 Jun;73(8):2165-70. Blood. 1989. PMID: 2730954 Free article.

6

T-cell receptor gamma chain gene rearrangement in acute myelogenous leukemia--evidence for lymphoid lineage prematurity.

Lee MS, Chang KS, Trujillo JM, McCredie KB, Keating MJ, Freireich EJ, Stass SA. Lee MS, et al. Hematol Pathol. 1987;1(2):93-8. Hematol Pathol. 1987. PMID: 2848796

7

Uses of polymerase chain reaction in leukemia: detection of minimal residual disease and identification of novel genetic mutations.

Lee MS, Stass SA. Lee MS, et al. Cancer Treat Res. 1993;64:35-44. doi: 10.1007/978-1-4615-3086-2_3. Cancer Treat Res. 1993. PMID: 8095797 Review. No abstract available.

8

BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapy.

Guo JQ, Lian JY, Xian YM, Lee MS, Deisseroth AB, Stass SA, Champlin RE, Talpaz M, Wang JY, Arlinghaus RB. Guo JQ, et al. Among authors: lee ms. Blood. 1994 Jun 15;83(12):3629-37. Blood. 1994. PMID: 8204887 Free article.

9

Detection of the AML1/ETO fusion transcript in the t(8;21) masked translocation in acute myelogenous leukemia.

Maruyama F, Yang P, Stass SA, Cork A, Freireich EJ, Lee MS, Chang KS. Maruyama F, et al. Among authors: lee ms. Cancer Res. 1993 Oct 1;53(19):4449-51. Cancer Res. 1993. PMID: 8402610

10

The breakpoint cluster region site in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Clinical, laboratory, and prognostic correlations.

Verschraegen CF, Kantarjian HM, Hirsch-Ginsberg C, Lee MS, O'Brien S, Rios MB, Stass SA, Keating M, Talpaz M. Verschraegen CF, et al. Among authors: lee ms. Cancer. 1995 Sep 15;76(6):992-7. doi: 10.1002/1097-0142(19950915)76:6<992::aid-cncr2820760612>3.0.co;2-l. Cancer. 1995. PMID: 8625225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,006 results

Search Page